367 related articles for article (PubMed ID: 18684282)
101. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
[TBL] [Abstract][Full Text] [Related]
102. Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
Almendral J; Arribas F; Wolpert C; Ricci R; Adragao P; Cobo E; Navarro X; Quesada A; ; ;
Europace; 2008 May; 10(5):528-35. PubMed ID: 18390985
[TBL] [Abstract][Full Text] [Related]
103. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review.
Freedenberg V; Thomas SA; Friedmann E
Heart Fail Clin; 2011 Jan; 7(1):59-68. PubMed ID: 21109208
[TBL] [Abstract][Full Text] [Related]
104. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
[TBL] [Abstract][Full Text] [Related]
105. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure.
Denollet J; Vrints CJ; Conraads VM
Brain Behav Immun; 2008 Jul; 22(5):736-43. PubMed ID: 18068948
[TBL] [Abstract][Full Text] [Related]
106. Type D personality and mortality in peripheral arterial disease: a pilot study.
Aquarius AE; Smolderen KG; Hamming JF; De Vries J; Vriens PW; Denollet J
Arch Surg; 2009 Aug; 144(8):728-33. PubMed ID: 19687376
[TBL] [Abstract][Full Text] [Related]
107. Anxiety and depression in patients with an implantable cardioverter defibrillator and their partners: a longitudinal study.
VAN DEN Broek KC; Heijmans N; VAN Assen MA
Pacing Clin Electrophysiol; 2013 Mar; 36(3):362-71. PubMed ID: 23252886
[TBL] [Abstract][Full Text] [Related]
108. Anxiety disorders in patients with implantable cardioverter defibrillators: frequency, course, predictors, and patients' requests for treatment.
Lang S; Becker R; Wilke S; Hartmann M; Herzog W; Löwe B
Pacing Clin Electrophysiol; 2014 Jan; 37(1):35-47. PubMed ID: 24102228
[TBL] [Abstract][Full Text] [Related]
109. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
Spencker S; Coban N; Koch L; Schirdewan A; Müller D
Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
[TBL] [Abstract][Full Text] [Related]
110. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
111. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
[TBL] [Abstract][Full Text] [Related]
112. Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.
Tomaske M; Bauersfeld U
Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S35-7. PubMed ID: 18226033
[TBL] [Abstract][Full Text] [Related]
113. Trajectories of perceived emotional and physical distress in patients with an implantable cardioverter defibrillator.
van den Broek KC; Kupper N; van der Voort PH; Alings M; Denollet J; Nyklíček I
Int J Behav Med; 2014 Feb; 21(1):149-59. PubMed ID: 23160996
[TBL] [Abstract][Full Text] [Related]
114. Relation of statin therapy to psychological functioning in patients with an implantable cardioverter defibrillator.
Hoogwegt MT; Theuns DA; Kupper N; Jordaens L; Pedersen SS
Am J Cardiol; 2013 Apr; 111(8):1169-74. PubMed ID: 23360769
[TBL] [Abstract][Full Text] [Related]
115. [Cardiological and psychosocial status of patients with malignant ventricular arrhythmias before implantation of a cardioverter defibrillator. First results from the German Austrian ICD Multicenter Study (GAIMS)].
Herrmann-Lingen C; Fritzsche K; Kanwischer H; Drinkmann A; Rabung S; Bergmann G;
Psychother Psychosom Med Psychol; 2004 Aug; 54(8):308-19. PubMed ID: 15284942
[TBL] [Abstract][Full Text] [Related]
116. Nitrous oxide sedation reduces discomfort caused by atrial defibrillation shocks.
Ujhelyi M; Hoyt RH; Burns K; Fishman RS; Musley S; Silverman MH
Pacing Clin Electrophysiol; 2004 Apr; 27(4):485-91. PubMed ID: 15078402
[TBL] [Abstract][Full Text] [Related]
117. Outcomes, problems and quality of life with the implantable cardioverter defibrillator.
Reid SS; McKinley S; Nagy S
Aust J Adv Nurs; 1999; 16(4):14-9. PubMed ID: 10603767
[TBL] [Abstract][Full Text] [Related]
118. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
119. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
[TBL] [Abstract][Full Text] [Related]
120. Psychological adaptation to ICDs and the influence of anxiety sensitivity.
Lemon J; Edelman S
Psychol Health Med; 2007 Mar; 12(2):163-71. PubMed ID: 17365897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
